{
  "actions": [
    {
      "acted_at": "2005-06-30",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2005-06-30",
      "action_code": "H11100",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",
      "type": "referral"
    },
    {
      "acted_at": "2005-06-30",
      "action_code": "H11100",
      "committees": [
        "HSJU"
      ],
      "references": [],
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",
      "type": "referral"
    },
    {
      "acted_at": "2005-06-30",
      "action_code": "H11100",
      "committees": [
        "HSWM"
      ],
      "references": [],
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",
      "type": "referral"
    },
    {
      "acted_at": "2005-07-29",
      "action_code": "",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "text": "Referred to the Subcommittee on Health.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "hr3154-109",
  "bill_type": "hr",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF",
      "subcommittee": "Subcommittee on Health",
      "subcommittee_id": "14"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Ways and Means",
      "committee_id": "HSWM"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Judiciary",
      "committee_id": "HSJU"
    }
  ],
  "congress": "109",
  "cosponsors": [
    {
      "bioguide_id": "B001229",
      "district": "3",
      "name": "Baird, Brian",
      "original_cosponsor": true,
      "sponsored_at": "2005-06-30",
      "state": "WA",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "B000072",
      "district": "6",
      "name": "Baker, Richard H.",
      "original_cosponsor": true,
      "sponsored_at": "2005-06-30",
      "state": "LA",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "B001244",
      "district": "1",
      "name": "Bonner, Jo",
      "original_cosponsor": true,
      "sponsored_at": "2005-06-30",
      "state": "AL",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "D000602",
      "district": "7",
      "name": "Davis, Artur",
      "original_cosponsor": true,
      "sponsored_at": "2005-06-30",
      "state": "AL",
      "title": "Rep.",
      "withdrawn_at": "2005-07-18"
    },
    {
      "bioguide_id": "G000550",
      "district": "11",
      "name": "Gingrey, Phil",
      "original_cosponsor": true,
      "sponsored_at": "2005-06-30",
      "state": "GA",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "L000552",
      "district": "18",
      "name": "LaHood, Ray",
      "original_cosponsor": true,
      "sponsored_at": "2005-06-30",
      "state": "IL",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "M001142",
      "district": "2",
      "name": "Matheson, Jim",
      "original_cosponsor": true,
      "sponsored_at": "2005-06-30",
      "state": "UT",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "W000267",
      "district": "15",
      "name": "Weldon, Dave",
      "original_cosponsor": true,
      "sponsored_at": "2005-06-30",
      "state": "FL",
      "title": "Rep.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2005-06-30",
  "number": "3154",
  "official_title": "To provide incentives for pharmaceutical companies, biotechnology companies, and medical device companies to invest in research and development with respect to antibiotic drugs, antivirals, diagnostic tests, and vaccines that may be used to identify, treat, or prevent an infectious disease, and for other purposes.",
  "popular_title": null,
  "related_bills": [],
  "short_title": "Infectious Diseases Research and Development Act of 2005",
  "sponsor": {
    "bioguide_id": "C000962",
    "district": null,
    "name": "Cubin, Barbara",
    "state": "WY",
    "title": "Rep.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2005-06-30",
  "subjects": [
    "Administrative procedure",
    "Administrative remedies",
    "Antibiotics",
    "Authorization",
    "Bacterial diseases",
    "Building construction",
    "Capital investments",
    "Clinical trials",
    "Commerce",
    "Communicable diseases",
    "Congress",
    "Congressional reporting requirements",
    "Department of Health and Human Services",
    "District courts",
    "Drug approvals",
    "Drug industry",
    "Drug resistance in microorganisms",
    "Economics and Public Finance",
    "Epidemics",
    "Federal advisory bodies",
    "Federal aid to research",
    "Finance and Financial Sector",
    "Food and Drug Administration (FDA)",
    "Government Operations and Politics",
    "Government paperwork",
    "Health",
    "Income tax",
    "Influenza",
    "Intellectual property",
    "Inventions",
    "Investment tax credit",
    "Jurisdiction",
    "Laboratories",
    "Law",
    "Lung diseases",
    "Medical supplies",
    "Medical technology",
    "Medical tests",
    "Patents",
    "Pharmaceutical research",
    "Product development",
    "Products liability",
    "Punitive damages",
    "Research and development",
    "Research and development facilities",
    "Research grants",
    "Science, Technology, Communications",
    "Small business",
    "Standards",
    "Subsidies",
    "Tax credits",
    "Tax deductions",
    "Taxation",
    "Vaccines",
    "Virus diseases"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in House",
    "asOf": "2005-06-30",
    "date": "2005-09-21T20:18:31Z",
    "text": "Infectious Diseases Research and Development Act of 2005 - Limits the liability of manufacturers of qualified infectious disease products by limiting: (1) punitive damages unless the manufacturer acted with malicious intent to injure the individual or deliberately failed to avoid unnecessary injury that the manufacturer knew the individual was substantially certain to suffer; and (2) non-economic damages to $250,000.\n\nSets forth circumstances under which the term of a patent may be extended for qualified infectious disease products.\n\nRequires the Secretary of Health and Human Services to designate qualified infectious disease products as fast-track products for approval.\n\nAmends the Public Health Service Act to require the Director of the National Institute of Allergy and Infectious Diseases to expand and intensify efforts to assist small manufacturers to conduct end-stage clinical trials on qualified infectious disease products.\n\nAmends the Internal Revenue Code to establish an infectious disease research credit and a qualified infectious disease products manufacturing facilities investment credit.\n\nAuthorizes appropriations for activities related to antimicrobial resistance.\n\nEstablishes the Commission on Infectious Diseases Product Development to identify infectious pathogens that are a significant threat to public health and make recommendations to the Secretary on how best to address such pathogens.\n\nAmends the Federal Food, Drug, and Cosmetic Act to require the Secretary, acting through the Commissioner of Food and Drugs, to issue guidelines for the conduct of clinical trials with respect to antibiotic drugs."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Infectious Diseases Research and Development Act of 2005",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To provide incentives for pharmaceutical companies, biotechnology companies, and medical device companies to invest in research and development with respect to antibiotic drugs, antivirals, diagnostic tests, and vaccines that may be used to identify, treat, or prevent an infectious disease, and for other purposes.",
      "type": "official"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Infectious Diseases Research and Development Act of 2005",
      "type": "short"
    }
  ],
  "updated_at": "2023-01-13T04:47:49Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/109/hr/BILLSTATUS-109hr3154.xml"
}